NR1I2 and neoplasm: We demonstrate that PXR down-regulation decreased CSCs chemoresistance (Figure 4a) and chemotherapy-induced CSC enrichment and it also significantly delayed tumor relapse after Folfiri treatment of xenografted animals (Figure 6).